Usage of antibiotics in the intensive care units of an academic tertiary-level hospital

References

• Brink AJ, Coetzee J, Corcoran C, et al. Emergence of OXA-48 and OXA-181 Carbapenemases among Enterobacteriaceae in South Africa and Evidence of In Vivo selection of colistin resistance as a consequence of selective decontamination of the gastrointestinal tract. J Clin Microbiol 2013;51(1):369–72. Available from: http://jcm.asm.org/content/51/1/369.full doi: 10.1128/JCM.02234-12
   PubMed Web of Science ®Google Scholar
• Mammina C, Bonura C, Bernardo D, et al. Ongoing spread of colistin-resistant Klebsiella pneumoniae in different wards of an acute general hospital, Italy, June to December 2011. Eur Commun Dis Bull. 2012;17(33)ii:20248. Available from: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20248
   Google Scholar
• Halaby T, al Naiemi N, Kluytmans J, et al. Emergence of colistin resistance in Enterobacteriaceae after the introduction of selective digestive tract decontamination in an intensive care unit. Antimicrob Agents Chemother. 2013;57(7):3224–9. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3697390/ doi: 10.1128/AAC.02634-12
   PubMed Web of Science ®Google Scholar
• Del Franco M, Paone L, Novati R, et al. Molecular epidemiology of carbapenem resistant Enterobacteriaceae in Valle d’Aosta region, Italy, shows the emergence of KPC-2 producing Klebsiella pneumoniae clonal complex 101 (ST101 and ST1789). BMC Microbiol. 2015;15(1):260. Available from: https://bmcmicrobiol.biomedcentral.com/articles/10.1186/s12866-015-0597-z
   PubMedGoogle Scholar
• Jayol A, Poirel L, Dortet L, et al. National survey of colistin resistance among carbapenemase-producing Enterobacteriaceae and outbreak caused by colistin-resistant OXA-48-producing Klebsiella pneumoniae, France, 2014. Eur Commun Dis Bull. 2016;21(37). Available from: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=22579
   Google Scholar
• National Department of Health. A practical guide to antimicrobial stewardship in South Africa. [cited 2017 June 14]. Available from: http://www.health.gov.za/index.php/antimicrobial-resistance?download=1493:ams-guidelines-ndoh-draft-v1-0.
   Google Scholar
• Wasserman S, Boyles T, Mendelsohn M. A pocket guide to antibiotic prescribing for adults in South Africa. First published 2014 © Sean Wasserman, Tom Boyles, Marc Mendelson. [cited 2017 August 4]. Available from: http://www.fidssa.co.za/Content/Documents/SAASP_Antibiotic_Guidelines_2015.pdf
   Google Scholar
• Paruk F, Richards G, Scribante J, et al. Antibiotic prescription practices and their relationship to outcome in South Africa: findings of the prevalence of infection in South Africa intensive care units (PISA) study. S Afr Med J. 2012;102(7):613–6. Available from: http://www.samj.org.za/index.php/samj/article/view/5833/4292 doi: 10.7196/SAMJ.5833
   PubMed Web of Science ®Google Scholar
• Stevens DL, Gibbons AE, Bergstrom R, et al. The Eagle effect revisited: efficacy of clindamycin, erythromycin, and penicillin in the treatment of streptococcal myositis. J Infect Dis. 1988 Jul 1;158(1):23–8. Available from: https://academic.oup.com/jid/article-abstract/158/1/23/786909 doi: 10.1093/infdis/158.1.23
   PubMed Web of Science ®Google Scholar
• Badar VA, Navale SB. Study of prescribing pattern of antimicrobial agents in medicine intensive care unit of a teaching hospital in central India. J Assoc Physicians India. 2012;60:20–3. Available from: http://www.japi.org/april_2012/04_oa_study_of_prescribing.pdf
   PubMedGoogle Scholar
• Chunnilall D, Peer AK, Naidoo I, et al. An evaluation of antibiotic prescribing patterns in adult intensive care units in a private hospital in KwaZulu-Natal. S Afr J Infect Dis. 2015;30:17–22. Available from: http://www.sajei.co.za/index.php/SAJEI/article/view/620
   Web of Science ®Google Scholar
• Rahal JJ, Urban C, Horn D, et al. Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial Klebsiella. JAMA. 1998;280(14):1233–1237. Available from: http://jamanetwork.com/journals/jama/fullarticle/188047 doi: 10.1001/jama.280.14.1233
   PubMed Web of Science ®Google Scholar
• Bassetti M, Di Biagio A, Rebesco B, et al. The effect of formulary restriction in the use of antibiotics in an Italian hospital. Eur J Clin Pharmacol. 2001;57(6–7):529–34. Available from: https://link.springer.com/content/pdf/10.1007/s002280100338.pdf doi: 10.1007/s002280100338
   PubMed Web of Science ®Google Scholar
• Dellit TH, Owens RC, McGowan JE Jr., et al. Infectious diseases society of America and the society for healthcare epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis. 2007;44(2):159–77. Available from: http://www.idsociety.org/uploadedFiles/IDSA/Guidelines-Patient_Care/PDF_Library/Antimicrobial%20Stewardship.pdf doi: 10.1086/510393
   PubMed Web of Science ®Google Scholar
• Meyer KS, Urban C, Eagan JA, et al. Nosocomial outbreak of Klebsiella infection resistant to late-generation Cephalosporins. Ann Intern Med. 1993;119(5):353–358. Available from: http://www.ajicjournal.org/article/0196-6553(95)90013-6/abstract doi: 10.7326/0003-4819-119-5-199309010-00001
   PubMed Web of Science ®Google Scholar
• Labuschagne Q, Shellack N, Gous A, et al. COLISTIN: adult and paediatric guideline for South Africa, 2016. S Afr J Infect Dis. 2016;31(1):3–7. Available from: http://www.tandfonline.com/doi/pdf/10.1080/23120053.2016.1144285
   Web of Science ®Google Scholar
• Doherty WL, Winter B. Prokinetic agents in critical care. Crit Care. 2003;7(3):206–8. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC270665/ doi: 10.1186/cc1849
   PubMed Web of Science ®Google Scholar
• Kaplan JB. Antibiotic-induced biofilm formation. Int J Artif Organs. 2011;34(9):737–51. Available from: http://www.artificial-organs.com/article/antibiotic-induced-biofilm-formation-ijao-d-11-00105 doi: 10.5301/ijao.5000027
   PubMed Web of Science ®Google Scholar
• Giamarellou H. Aminoglycosides plus beta-lactams against gram-negative organisms: evaluation of in vitro synergy and chemical interactions. Am J. Med. 1986;80(6):126–37. Available from: http://www.sciencedirect.com/science/article/pii/0002934386904900 doi: 10.1016/0002-9343(86)90490-0
   PubMedGoogle Scholar
• Richards GA, Joubert IA, Brink AJ. Optimizing the administration of antibiotics in critically ill patients. S Afr Med J. 2015;105(5):419. Available from: http://www.scielo.org.za/scielo.php?script=sci_arttext&pid=S0256-95742015000500035 doi: 10.7196/SAMJ.9649
   Google Scholar
• Luyt C-E, Bréchot N, Trouillet J-L, et al. Antibiotic stewardship in the intensive care unit. Crit Care. 2014;18:215–480. Available from: https://ccforum.biomedcentral.com/articles/10.1186/s13054-014-0480-6
   PubMedGoogle Scholar
• Kumar A, Singh NP. Antimicrobial dosing in critically ill patients with sepsis-induced acute kidney injury. Indian J Crit Care Med. 2015;19(2):99–108. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4339912/ doi: 10.4103/0972-5229.151018
   PubMed Web of Science ®Google Scholar
• Lawrence KL, Kollef MH. Antimicrobial stewardship in the intensive care unit advances and obstacles. Am J Respir Crit Care Med. 2009;179(6):434–38. Available from: http://www.atsjournals.org/doi/full/10.1164/rccm.200809-1394CP
   PubMed Web of Science ®Google Scholar
• Thursky KA, Buising KL, Bak N, et al. Reduction of broad-spectrum antibiotic use with computerized decision support in an intensive care unit. Int J Qual Health Care. 2006;18(3):224–31. Available from: https://academic.oup.com/intqhc/article/18/3/224/1786346/Reduction-of-broad-spectrum-antibiotic-use-with doi: 10.1093/intqhc/mzi095
   PubMed Web of Science ®Google Scholar
• Brink AJ, van den Bergh D, Mendelson M, et al. Passing the baton to pharmacists and nurses: new models of antibiotic stewardship for South Africa?. S Afr Med J. 2016;106(10):947–948. Available from: http://www.samj.org.za/index.php/samj/article/view/11448 doi: 10.7196/SAMJ.2016.v106i10.11448
   PubMed Web of Science ®Google Scholar